Scientists have established how bowel cancer turns aggressive, leading the way for potential new drug treatments.
Researchers in Cardiff and Glasgow are behind the study, which showed how a particular protein stimulates tumours, making them more likely to spread.
The protein called AKT is triggered when another, called Pten, is faulty and coincides with a third protein known as APC.